Clinical Trial Update: Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event

View source ↗

Summary

A clinical trial from the Chinese University of Hong Kong is recruiting to test rapid escalation of lipid-lowering therapy to reduce recurrent cardiovascular ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hyperlipidemia

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Hyperlipidemia, Cardio Vascular Disease | Status: RECRUITING